Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
AUTOR(ES)
Goldstein, F W
RESUMO
The activities of teicoplanin and vancomycin against 362 coagulase-negative staphylococci were determined by an agar dilution method. At the 4- and 32-micrograms/ml breakpoint levels of the National Committee for Clinical Laboratory Standards, 23.2% of the strains were intermediate and 1.7% were resistant to teicoplanin, in contrast to less than 0.3% intermediate to vancomycin. Resistant strains belonged to the species Staphylococcus epidermidis (74%) and S. haemolyticus (19%).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171714Documentos Relacionados
- Emergence of teicoplanin-resistant coagulase-negative staphylococci.
- Decreased Susceptibilities to Teicoplanin and Vancomycin among Coagulase-Negative Methicillin-Resistant Clinical Isolates of Staphylococci
- Biotyping coagulase-negative staphylococci.
- Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
- Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
